Role of lifestyle modification in the management of polycystic ovary syndrome
- PMID: 16772159
- DOI: 10.1016/j.beem.2006.03.008
Role of lifestyle modification in the management of polycystic ovary syndrome
Abstract
Overweight and obesity are common findings in polycystic ovary syndrome (PCOS). Obesity-particularly central obesity-is strongly indicated as a cause of insulin resistance, a central feature of PCOS. The prevalence of obesity is reaching epidemic proportions in many developed countries, and this increase is of particular concern in adolescent women. Obesity worsens both the metabolic and endocrine profiles in PCOS and may decrease the response to treatment. In the short term, weight reduction improves both metabolic and endocrine aspects of PCOS as well as clinical markers such as ovulation. However, extreme non-surgical efforts to lose weight are rarely successful and are associated with high rates of weight regain. Lifestyle modification with modest weight loss goals of 5-10% appear to be equally effective in restoring fertility and may be more compatible with long-term success; however, further research is needed.
Similar articles
-
Polycystic ovary syndrome in the Indian Subcontinent.Semin Reprod Med. 2008 Jan;26(1):22-34. doi: 10.1055/s-2007-992921. Semin Reprod Med. 2008. PMID: 18181079 Review.
-
Obesity and lifestyle management in polycystic ovary syndrome.Clin Obstet Gynecol. 2007 Mar;50(1):277-94. doi: 10.1097/GRF.0b013e31802f54c8. Clin Obstet Gynecol. 2007. PMID: 17304042
-
Polycystic ovary syndrome in the adolescent.Obstet Gynecol Clin North Am. 2009 Mar;36(1):129-52. doi: 10.1016/j.ogc.2008.12.004. Obstet Gynecol Clin North Am. 2009. PMID: 19344852 Review.
-
The impact of obesity on reproduction in women with polycystic ovary syndrome.BJOG. 2006 Oct;113(10):1148-59. doi: 10.1111/j.1471-0528.2006.00990.x. Epub 2006 Jul 7. BJOG. 2006. PMID: 16827825 Review.
-
Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome.Best Pract Res Clin Obstet Gynaecol. 2004 Oct;18(5):719-36. doi: 10.1016/j.bpobgyn.2004.05.003. Best Pract Res Clin Obstet Gynaecol. 2004. PMID: 15380143 Review.
Cited by
-
Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women.Int J Womens Health. 2023 May 29;15:837-843. doi: 10.2147/IJWH.S403347. eCollection 2023. Int J Womens Health. 2023. PMID: 37275514 Free PMC article.
-
Effects of a Dulaglutide plus Calorie-Restricted Diet versus a Calorie-Restricted Diet on Visceral Fat and Metabolic Profiles in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial.Nutrients. 2023 Jan 20;15(3):556. doi: 10.3390/nu15030556. Nutrients. 2023. PMID: 36771262 Free PMC article. Clinical Trial.
-
Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study.Health Qual Life Outcomes. 2010 Dec 20;8:149. doi: 10.1186/1477-7525-8-149. Health Qual Life Outcomes. 2010. PMID: 21171983 Free PMC article.
-
Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress.Indian J Endocrinol Metab. 2015 Nov-Dec;19(6):731-43. doi: 10.4103/2230-8210.167548. Indian J Endocrinol Metab. 2015. PMID: 26693422 Free PMC article. Review.
-
Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study.J Pediatr Psychol. 2009 Mar;34(2):156-63. doi: 10.1093/jpepsy/jsn057. Epub 2008 Jun 12. J Pediatr Psychol. 2009. PMID: 18556675 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical